PET或PET-CT在肿瘤筛查中的应用价值

汪太松; 赵晋华; 宋建华

汪太松 , 赵晋华 , 宋建华

文章导航 > 国际放射医学核医学杂志 > 2007, 31 > 6: (337-341)

引用本文:

Citation:

PET或PET-CT在肿瘤筛查中的应用价值

200080 上海, 上海交通大学附属第一人民医院核医学科

通讯作者: 赵晋华, zjh1963@gmail.com ;

中图分类号: R817.4

PET or PET-CT with cancer screening

Department of Nuclear Medicine, The First People's Hospital, Shanghai Jiaotong University, Shanghai 200080, China

Corresponding author: ZHAO Jin-hua, zjh1963@gmail.com ;

CLC number: R817.4

摘要: 尽管国内外许多医疗机构都在进行肿瘤筛查,但对如何合理使用现代医学手段对肿瘤筛查仍有争议,目前达成共识的是对肿瘤筛查的评论和定性需要可靠的实验数据,而不是想当然、假设。近年来,PET或PET-CT也开始应用于全身肿瘤筛查,在此,讨论了全身PET或PET-CT肿瘤筛查的现状、经济性、辐射安全和统计学资料。
- 氟脱氧葡萄糖F18 /
- 体层摄影术,发射型计算机 /
- 体层摄影术,X线计算机 /
- 肿瘤筛查
Abstract: At present, cancer screening remains a lot of debate in contemporary medical practice. Many constitutes have done a lot of experiments in cancer screening. The same version is that recommendations and decisions regarding cancer screening should be based on reliable data, not self-approbation. Now, some institutes advocate ¹⁸F-FDG PET or ¹⁸F-FDG PET-CT for cancer screening, here, discussed status quo, potential financial, radiation safety and statistical data in ¹⁸F-FDG PET or ¹⁸F-FDG PET-CT cancer screening.
- Fluorodeoxyglucose FI8 /
- Tomography,emission-computed /
- Tomography,X-ray computed /
- Cancer screening
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Yasuda S, Ide M, Fujii H, et al. Application of positron emission tomography imaging to cancer screening. Br J Cancer, 2000, 83(12):1607-1611.
[2]	Chen YK, Ding HJ, Su CT, et al. Application of PET and PET-CT imaging for cancer screening. Anticancer Res, 2004, 24(6):4103-4108.
[3]	Ide M, Suzuki Y. Is whole-body FDG-PET valuable for health screening?. Eur J Nucl Med Mol Imaging, 2005, 32(3):339-341.
[4]	Aghini-Lombardi F, Antonangeli L, Martino E, et al. The spectrum of thyroid disorders in an iodine-deficient community:the Pescopugano survey. J Clin Endocrinol Metab, 1999, 84(2):561-566.
[5]	Brander AE, Viikinkoski VP, Nickels JI, et al. Importance of thyroid abnormalities detected at US screening:a 5-year follow-up. Radiology, 2000, 215(3):801-806.
[6]	Pacini F, Burroni L, Ciuoli C, et al. Management of thyroid nodules:a clinicopathological, evidence-based approach. Eur J Nucl Med Mol Imaging, 2004, 31(10):1443-1449.
[7]	Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US:Society of Radiologists in Ultrasound consensus conference statement. Radiology, 2005, 237(3):794-800.
[8]	Kang KW, Kim SK, Kang HS, et al. Prevalence and risk of cancer of focal thyroid incident Loma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metaba, 2003, 88(9):4100-4104.
[9]	Cohen MS, Arslan N, Dohdashti F, et al. Risk of malignancy in thyroid ineidentalomas identified by flurodeoxyglueose positron emission tomography. Surgery, 2001, 130(6):941-946.
[10]	Kim TY, Kim WB, Ryu JS, et al. ¹⁸F-FDG uptake in thyroid from PET for evaluation in cancer patients:high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope, 2005, 115(6):1074-1078.
[11]	Yasuda S, Fujii H, Nakahara T, et al. ¹⁸F-FDG PET detection of colonic adenomas. J Nucl Med, 2001, 42(7):989-992.
[12]	Israel O, Yefremov N, Bar-Shalom R, et al. PET/CT detection of unexpected gastrointestinal foci of ¹⁸F-FDG uptake:incidence, localization patterns, and clinical significance. J Nucl Med. 2005, 46(5):758-762.
[13]	Kamel EM, Thumshim M, Truninger K, et al. Signigicance of incidental ¹⁸F-FDG accumulations in the gastrointestinal tract in PET-CT:correlation with endoscopic and histopathologic results. J Nucl Med, 2004, 45(11):1804-1810.
[14]	Silverman D, Screening ¹⁸F-FDG whole-body scanning:AWESOMPET or FALSPOS-PET?. J Nucl Med, 2005, 46(5):717.
[15]	Schöder H, Yeung HW, Gonen M, et al. Head and neck cancer:clinical usefulness and accuracy of PET-CT image fusion. Radiology, 2004, 231(1):65-72.
[16]	Cohade C, Osman M, Leal J, et al. Direct comparison of ¹⁸F-FDG PET and PET-CT in patients with colorectal carcinoma. J Nucl Med, 2003, 44(11):1797-1803.
[17]	Antoch G, Saoudi N, Kuchl H, et al. Accuracy of whole-body dualmodality ¹⁸F-FDG PET and PET-CT for tumor staging in solid tumors:comparison with CT and PET. J Clin Oncol, 2004, 22(21):4357-4368.
[18]	Deloar HM, Fujiwara T, Shidahara M, et al. Estimation of absorbed dose for ¹⁸F-FDG using whole-body positron emission tomography and magnetic resonance imaging. Eur J Nucl Med, 1998, 25(6):565-574.
[19]	Brix G. Lechel U, Glatting G, et al. Radiation exposure of patients undergoing whole-body dual-modality ¹⁸F-FDG PET-CT examinations. J Nucl Med, 2005, 46(4):608-613.
[20]	International Commission on Radiological Protection.Recommendatio ns of the International Commission on Radiological Protection.Oxford. England:Pergamon Press:1991. Publication 60.
[21]	Black WC. Over diagnosis:An under recognized cause of confusion and harm in cancer screening. J Natl Cancer Inst, 2000, 92(16):1280-1282.
[22]	Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst, 2002, 94(3):167-173.
[23]	Kopans DB, Monsees B, Feig SA. Screening for cancer:when it valid? Lessons from the mammography experience. Radiology, 2003, 229(2):319-327.

[1]	叶慧 , 莫逸 , 谢爱民 , 彭翔 . ¹⁸F-氟脱氧葡萄糖PET-CT与99nTc-亚甲基二膦酸盐骨显像诊断转移性骨肿瘤的对比研究. 国际放射医学核医学杂志, 2008, 32(3): 147-150.
[2]	张玉娜 , 赵晋华 . ¹⁸F-氟脱氧葡萄糖PET-CT在头颈部肿瘤临床诊治中的价值. 国际放射医学核医学杂志, 2007, 31(6): 359-362.
[3]	杨吉刚 , 李春林 . ¹⁸F-氟脱氧葡萄糖PET及PET-CT在食管癌中的. 国际放射医学核医学杂志, 2007, 31(1): 31-33.
[4]	赵德善 , 乔振华 . ¹⁸F-氟脱氧葡萄糖PET-CT在淋巴瘤中的应用价值. 国际放射医学核医学杂志, 2007, 31(3): 141-144.
[5]	张悦 . ¹⁸F-氟脱氧葡萄糖PET和PET-CT在结直肠癌术后复发或转移中的应用价值. 国际放射医学核医学杂志, 2007, 31(1): 34-36.
[6]	曹霞 , 谢爱民 , 莫逸 , 彭翔 . ¹⁸F-氟脱氧葡萄糖PET-CT在非小细胞肺癌临床分期及经治患者疗效评价中的应用. 国际放射医学核医学杂志, 2008, 32(4): 214-216.
[7]	邢岩 , 赵晋华 . ¹⁸F-氟脱氧葡萄糖PET及PET-CT早期诊断肿瘤复发. 国际放射医学核医学杂志, 2007, 31(6): 341-344.
[8]	吕慧清 , 张中民 , 吕仲虹 . ¹⁸F-氟代脱氧葡萄糖PET在恶性肿瘤适形放射治疗中的价值. 国际放射医学核医学杂志, 2006, 30(6): 335-337.
[9]	孙琳 , 高再荣 , 张永学 . ¹⁸F-氟代脱氧葡萄糖PET-CT用于恶性肿瘤治疗疗效评估与监测. 国际放射医学核医学杂志, 2006, 30(6): 328-331.
[10]	陈香 , 赵晋华 . PET及PET-CT在监测肿瘤治疗效果中的价值. 国际放射医学核医学杂志, 2007, 31(6): 354-358.
[11]	宋建华 , 赵晋华 , 邢岩 . 胸、腹部肿瘤PET-CT扫描方案的设置与选择. 国际放射医学核医学杂志, 2007, 31(6): 349-353.

点击查看大图

计量

文章访问数: 1355
HTML全文浏览量: 72
PDF下载量: 3

PET或PET-CT在肿瘤筛查中的应用价值

通讯作者: 赵晋华, zjh1963@gmail.com;

200080 上海, 上海交通大学附属第一人民医院核医学科

收稿日期: 2007-09-10

关键词:

摘要: 尽管国内外许多医疗机构都在进行肿瘤筛查,但对如何合理使用现代医学手段对肿瘤筛查仍有争议,目前达成共识的是对肿瘤筛查的评论和定性需要可靠的实验数据,而不是想当然、假设。近年来,PET或PET-CT也开始应用于全身肿瘤筛查,在此,讨论了全身PET或PET-CT肿瘤筛查的现状、经济性、辐射安全和统计学资料。